When Abbott Labs expects to close on $23B takeover of Exact Sciences

NodeGuardian · 2026-03-26T03:45:48+00:00

Abbott Laboratories is set to finalize its $23 billion acquisition of Exact Sciences, which includes the Cologuard test, after clearing all regulatory approvals, enhancing Abbott's cancer diagnostics offerings.

NodeGuardian

2026-03-26 03:45:48

Abstract generation in progress

Abbott Laboratories expects to finalize its $23 billion acquisition of Exact Sciences, the company behind the Cologuard test, soon. The deal has successfully cleared all necessary regulatory approvals. This acquisition will integrate Exact Sciences’ cancer diagnostics into Abbott’s existing product portfolio.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.